Bioventus BVS Cash Flow Statement (2020-2026)

NASDAQ BVS
$14.31 -0.37 (-2.52%)
As of: Aug 20, 2026 · 3:59 PM EDT
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Apr2021 Jul2021 Oct2021 Dec2021 Apr2022 Jul2022 Oct2022 Dec2022 Apr2023 Jul2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-2.27M-0.03M-0.40M-0.28M-44.66M-23.40M-74.43M-3.32M9.27M4.01M17.32M3.95M36.20M
Share-based Compensation (Quarter)
4.89M4.62M4.65M-10.80M1.85M-2.73M1.83M1.77M2.99M5.78M2.49M-11.26M6.06M-6.05M12.66M3.26M5.04M
Deferred Taxes (Quarter)
-0.72M-8.05M-17.02M-10.68M-7.19M-11.77M-2.66M-0.88M1.16M0.08M-8.18M-0.51M3.21M0.04M0.04M0.14M-1.13M0.14M-22.29M
Cash from Discontinued Operations (Quarter)
-0.86M-1.27M-2.17M
Gains from Investment Securities (Quarter)
0.65M-0.46M0.27M0.27M0.28M0.28M0.29M0.24M-0.10M0.29M0.29M0.30M0.48M0.34M
Asset Writedowns and Impairment (Quarter)
0.22M1.15M1.37M10.29M78.61M-0.98M31.87M2.03M0.18M0.65M0.19M0.10M-0.94M0.23M-0.09M
Change in Working Capital (Quarter)
0.71M1.13M
Change in Receivables (Quarter)
3.78M6.90M-4.42M25.57M-8.32M4.83M-13.16M1.83M-7.92M9.19M1.96M19.98M-17.06M5.79M-9.00M13.63M-1.82M-1.89M-7.32M17.94M
Change in Inventory (Quarter)
2.42M-1.69M-0.33M2.94M6.01M10.00M5.29M7.78M1.05M-8.13M4.07M4.29M2.52M5.56M1.88M2.81M-0.29M-12.97M2.65M-2.96M
Change in Accured Expenses (Quarter)
4.33M10.96M-7.92M25.66M-35.16M14.31M2.33M12.43M-25.83M5.79M-7.33M29.88M-21.33M16.62M-39.10M16.42M7.31M-4.44M-15.37M3.82M
Cash from Operations (Quarter)
10.59M13.12M-21.02M2.94M0.16M4.38M4.66M10.79M-10.48M10.37M-6.00M15.16M10.32M19.32M-19.33M25.94M30.10M37.97M8.93M19.87M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
189.20M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
8.52M11.69M12.48M12.38M13.59M16.94M16.47M14.60M13.83M12.46M11.79M13.09M12.28M12.40M11.87M12.05M11.40M11.69M11.21M10.95M
Investing Activities
Capital Expenditures (Quarter)
3.87M8.95M0.08M4.91M1.65M-6.22M3.56M-2.59M0.34M0.01M0.29M-0.09M-0.09M0.89M0.83M-0.63M1.79M0.58M0.53M0.96M
Acquisitions (Quarter)
-45.79M262.87M0.24M-0.01M104.61M
Divestments (Quarter)
-104.84M-11.51M46.40M-46.40M
Cash from Investing Activities (Quarter)
-13.19M-221.28M-4.67M-52.02M-56.33M-3.40M-15.07M45.01M-2.04M-0.59M-1.00M-0.08M-0.06M24.10M-0.83M-1.37M-0.47M-0.58M-0.57M-2.46M
Financing Activities
Other financing activities (Quarter)
-107.78M-0.01M-0.01M0.02M0.00M-0.04M-0.13M-0.17M-0.17M-0.18M-0.19M-0.19M1.74M-0.20M-0.21M-0.21M1.32M-0.22M-0.24M
Cash from Financing Activities (Quarter)
-4.35M176.31M9.21M7.66M50.65M-5.44M27.38M-62.25M8.23M-0.01M-4.24M-7.84M0.36M-42.85M0.95M-14.66M-19.98M-28.45M-23.14M-23.43M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
0.42M0.89M2.08M2.18M0.48M1.08M0.08M0.14M0.40M0.16M0.18M0.61M0.55M1.10M0.15M1.32M0.10M0.51M0.12M0.85M
Additional items
Exchange Rate Effect (Quarter)
-0.21M0.15M-0.07M-0.22M-0.24M1.05M0.46M0.24M-0.44M0.37M-0.54M-0.42M0.47M-2.06M0.43M0.20M-0.39M0.13M-0.61M-0.37M
Change in Cash (Quarter)
-7.15M-31.70M-16.56M-41.65M-6.62M-2.54M15.27M-17.71M-2.56M10.14M-11.79M6.82M11.08M-1.49M-18.78M10.11M9.25M9.07M-15.39M-6.39M
Free Cash Flow (Quarter)
6.71M4.17M-21.09M-1.98M-1.49M10.61M1.10M13.39M-10.82M10.37M-6.30M15.25M10.41M18.43M-20.16M26.57M28.31M37.39M8.40M18.91M
Net Cash Flow (Quarter)
-6.95M-31.85M-16.49M-41.43M-5.52M-4.46M16.97M-6.45M-4.29M9.77M-11.25M7.24M10.61M0.57M-19.21M9.91M9.65M8.94M-14.78M-6.02M